ARCHIVES

Markison leaving Bristol-Myers, two others promoted in reorganization.

This article is from The Cancer Letter archive.

Vol. 30 No. 05 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

Gloom and Doom Meeting of docs Turns Hopeful When Patient Offers Health Reform Proposal

February 5, 1993

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990

NCI Programs: Functional Imaging Centers Grant Program Approved By Advisors

December 11, 1998

US, Italy Plan Greater Scientific Collaboration

May 16, 2003

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997